REG - Trainline PLC - Transaction in Own Shares

TrainlineAnnouncement

Today 10:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260317:nRSQ9802Wa&default-theme=true

RNS Number : 9802W  Trainline PLC  17 March 2026

TRAINLINE PLC

TRANSACTIONS IN OWN SECURITIES

 

Trainline plc ("Trainline") announces that during the period between 9 March
2026 and 13 March 2026, it has purchased the following number of its ordinary
shares of 1 pence each on the London Stock Exchange and on Multilateral
Trading Facilities through Morgan Stanley & Co. International Plc.
Purchases were affected pursuant to the £150 million share purchase programme
announced by Trainline on 11 September 2025 (the "Programme") and in
accordance with the authority granted by shareholders at the 29 January 2026
General Meeting of Trainline:

Ordinary Shares

 Date of purchase  Number of ordinary shares purchased  Highest price paid per share  Lowest price paid per share  Volume weighted average price paid per share
 09/03/2026        772,086                              196.60p                       192.50p                      194.28p
 10/03/2026        768,123                              197.00p                       191.70p                      194.72p
 11/03/2026        780,303                              194.10p                       189.10p                      192.22p
 12/03/2026        801,627                              193.30p                       182.50p                      186.83p
 13/03/2026        762,823                              199.90p                       185.60p                      196.19p

 

The purchased shares will be cancelled.

The Company has purchased 37,397,005 ordinary shares under the Programme since
it commenced, representing £82,137,063.

Following the purchase of these shares, the remaining number of ordinary
shares in issue will be 378,005,294. Trainline does not old any ordinary
shares in Treasury. The figure of 378,005,294 may be used by shareholders (and
others with notification obligations) as the denominator for the calculations
by which they will determine if they are required to notify their interest in,
or a change to their interest in, the Company under the Disclosure and
Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it
applies in the UK (the Market Abuse Regulation), a full breakdown of the
individual trades made by Morgan Stanley acting as riskless principal for
Trainline as part of the share buyback programme is set out in the Schedule to
this announcement available through the link below:

http://www.rns-pdf.londonstockexchange.com/rns/9802W_1-2026-3-17.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/9802W_1-2026-3-17.pdf)

(http://www.rns-pdf.londonstockexchange.com/rns/9802W_1-2026-3-17.pdf)

This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.

Enquiries

For investor enquiries, Andrew Gillian
                   investors@trainline.com
(mailto:investors@trainline.com)

For media enquiries, Nichola Johnson-Marshall
 press@trainline.com (mailto:press@trainline.com)

 

Brunswick Group

Simone Selzer
                         trainline@brunswickgroup.com
(mailto:trainline@brunswickgroup.com) / +44 207 404 5959

 

About Trainline

Trainline (www.trainline.com (http://www.trainline.com) ) is the leading
independent rail and coach travel platform selling rail and coach tickets to
millions of travellers worldwide, enabling them to seamlessly search, book and
manage their journeys all in one place via its highly rated website and mobile
app. Trainline is a one‐stop shop for rail and coach travel bringing
together millions of routes, fares and journey times from rail and coach
carriers across Europe.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSGPURGWUPQGUM



            Copyright 2019 Regulatory News Service, all rights reserved